New Hampshire Medical Cannabis Registrations Jump 14.5% in Strongest Growth
The Granite State added 2,100 medical cannabis patients in 2024, marking the fastest program expansion since 2021 and signaling broader Northeast market momentum.
New Hampshire's medical cannabis program expanded by 14.5% in 2024, adding 2,100 new patients to reach nearly 17,000 total registrations. The growth represents the strongest annual increase since 2021, when the state's program was still in its early adoption phase.
The patient surge reflects broader trends across Northeast medical cannabis markets, where established programs continue expanding despite regulatory constraints on adult-use sales. New Hampshire remains one of the few states with medical-only cannabis programs, creating a more controlled environment that often drives higher per-patient spending compared to adult-use markets.
Multi-state operators with New Hampshire exposure benefit from the state's limited license structure, which restricts competition while serving a growing patient base. The 17,000-patient milestone puts New Hampshire's program on par with similarly sized medical markets, though the state's affluent demographics typically generate above-average revenue per patient.
The registration growth comes as neighboring states like Massachusetts and Maine operate mature adult-use markets, suggesting New Hampshire patients prefer the medical program's tax advantages and product consistency over cross-border purchases. This patient loyalty creates predictable revenue streams for licensed operators in the state.
New Hampshire's medical program growth supports the broader thesis that established cannabis markets continue expanding even without adult-use legalization. The 14.5% patient increase outpaces typical healthcare program growth rates, indicating cannabis adoption remains in expansion mode across demographic segments that previously avoided the market.